Literature DB >> 6024117

Studies on cyclophosphamide-induced tolerance to sheep erythrocytes.

A C Aisenberg.   

Abstract

Complete immunological tolerance to sheep cells can be induced in mice when cyclophosphamide is injected together with sheep cells or up to 72 hr before or 48 hr after the antigen. As is true for radiation-induced immune suppression, the drug is most effective when given in the 24 hr prior to antigen. Complete cyclophosphamide-induced immunological suppression requires large doses of sheep cells (6.2 x 10(9) cells), presumably to enable antigen to reach sequestered receptor sites. The cyclophosphamide tolerance system has been analyzed with the Jerne technique to determine plaque-forming cells and with isotopic methods to measure rates of nucleic acid synthesis. This drug suppression has been found to consist of two components. The first is nonspecific injury to the lymphoid system caused by the cytotoxic drug and is related to the proportion of spleen cells killed. The second is antigen-specific immunological tolerance and appears to correlate with profound depression of deoxyribonucleic acid synthesis in the surviving cells. This tolerance is thought to be most consistent with a mechanism in which antigenic stimulation in the presence of cyclophosphamide-inhibited DNA synthesis and mitosis leads to the elimination or death of the specific immunological clone. Tolerance induction with cyclophosphamide is associated with loss of the 19S hemolysin plaques which are seen in nonstimulated mouse spleen, implicating these cells in immune responsiveness. The ability to induce tolerance is lost on the 3rd postantigen day at the end of a 24-hr period in which 19S cells have increased 8-fold and 7S cells 200-fold. The data suggest that loss of sensitivity is due to the emergence on day 3 of drug-resistant plaque-forming cells, particularly those of the 19S variety. In the succeeding days after antigen injection there is a progressive increase in the resistance of plaque-forming cells to cyclophosphamide administration.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6024117      PMCID: PMC2138214          DOI: 10.1084/jem.125.5.833

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  STUDIES ON MOUSE ANTIBODIES. I. THE RESPONSE TO SHEEP RED CELLS.

Authors:  F L ADLER
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

4.  Drug-induced immunological tolerance.

Authors:  R SCHWARTZ; W DAMESHEK
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

5.  Phagocytosis of foreign red blood cells by the reticulo-endothelial system.

Authors:  B N HALPERN; G BIOZZI; B BENACERRAF; C STIFFEL
Journal:  Am J Physiol       Date:  1957-06

6.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

7.  Detection of agents which interfere with the immune response.

Authors:  H C NATHAN; S BIEBER; G B ELION; G H HITCHINGS
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

8.  Tolerance of erythrocytes in poultry:induction and specificity.

Authors:  N A MITCHISON
Journal:  Immunology       Date:  1962-05       Impact factor: 7.397

9.  Cyclophosphamide and urinary bladder toxicity.

Authors:  F S PHILIPS; S S STERNBERG; A P CRONIN; P M VIDAL
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

10.  Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency.

Authors:  D W Dresser; D H Wortis
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

View more
  31 in total

1.  Effect of cyclophosphamide on the growth of Rickettsia sennetsu in experimentally infected mice.

Authors:  N Tachibana; V Kobayashi
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  Comparison of the immunosuppressive efficacy of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on the primary and secondary immune response of mice to sheep erythrocytes.

Authors:  U Botzenhardt; E M Lemmel
Journal:  Agents Actions       Date:  1976-09

3.  Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses.

Authors:  K-W Peng; R Myers; A Greenslade; E Mader; S Greiner; M J Federspiel; A Dispenzieri; S J Russell
Journal:  Gene Ther       Date:  2012-04-05       Impact factor: 5.250

4.  Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus.

Authors:  M J Corbel; S M Eades
Journal:  Mycopathologia       Date:  1977-02-18       Impact factor: 2.574

5.  The role of the thymus for maturation of transferred bursa cells into immunocompetent B cells in chickens treated with cyclophosphamide.

Authors:  Y Hirota; Y Bito
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

6.  Regulation of immune response to SRBC: suppressor cell activity induced by soluble fraction of antigen.

Authors:  M L Lukić; A Janezić; L Popesković
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

7.  Suppression of thyroid lesions in rabbits by treatment with cyclophosphamide after the induction of thyroiditis.

Authors:  R M Nakamura; W O Weigle
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

8.  Aleutian disease of mink. Prevention of lesions by immunosuppression.

Authors:  A Cheema; J B Henson; J R Gorham
Journal:  Am J Pathol       Date:  1972-03       Impact factor: 4.307

9.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. II. Induction of delayed-type hypersensitivity.

Authors:  A J van Houte; H Snippe; G T Peulen; J M Willers
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

10.  Effect of immunosuppressive agents on normal phage-neutralizing antibody in the mouse.

Authors:  R D Karp; S G Bradley
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.